Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients
In KTRs with T2DM, GLP-1 RAs use was associated with substantial reductions in all-cause mortality, MAKEs, and MACEs compared to nonuse without increasing complications. However, the underutilization of GLP-1 RAs represents a significant opportunity to improve post-transplant outcomes in this high-risk population.
Authors
- Vin‐Cent Wu (ORCID: https://orcid.org/0000-0001-7935-0991)
- Thomas Tao-Min Huang (ORCID: https://orcid.org/0000-0002-9387-0798)
- Jui‐Yi Chen (ORCID: https://orcid.org/0000-0003-1376-7780)
- Li‐Chun Lin
Institutions
- National Taiwan University Hospital (TW)
- Chi Mei Medical Center (TW)
- Chia Nan University of Pharmacy and Science (TW)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1186/s12933-025-02649-0
- Citations
- 14
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 18.13